Why It Matters

MAXIMUS faces a fundamental credibility challenge: Congress is simultaneously demanding the company expand its administrative role in welfare programs while publicly accusing it of profiting from systems that deny eligible beneficiaries coverage. The core issue is whether MAXIMUS can convince lawmakers that its eligibility verification services reduce fraud—or whether its business model incentivizes administrative barriers that harm vulnerable populations.

The stakes are enormous. Federally mandated Medicaid work requirements beginning in 2027 will require massive new contracting for eligibility verification systems, representing significant revenue opportunity. But this expansion comes as the DOJ has launched aggressive fraud enforcement against healthcare contractors, senators are scrutinizing MAXIMUS’s track record, and the Congressional Budget Office projects 5.3 million Medicaid enrollees will lose coverage under new work requirements.

MAXIMUS’s strategy appears threefold: lobbying for "streamlined procurement" to reduce regulatory burden; joining a bipartisan coalition supporting the Work Opportunity Tax Credit; and maintaining low-profile in-house lobbying. The company is betting it can navigate between Republican demand for administrative efficiency and Democratic scrutiny of contractor conduct—a narrowing political space.

By the Numbers

MAXIMUS Inc. spent $620,000 on in-house lobbying in Q3 2025, modest compared to its historical $13.1 million spent since 2003 across over 500 disclosures.

The company engages 27 different lobbying firms, with significant relationships including M.J. Simon & Co. LLC ($1.87 million), McGuireWoods Consulting LLC ($2.59 million), and Dogwood Strategies LLC ($1.16 million).

The Q3 2025 team consists of Kathryn Leggieri, filing her first disclosure, and David M. Casey, who joined in July 2024. Neither has documented congressional staff experience.

The Agenda

MAXIMUS is lobbying on two primary fronts. First, advocating for streamlined government procurement and long-term contracting to reduce administrative burdens on federal contractors.

Second, supporting the Improve and Enhance the Work Opportunity Tax Credit Act (H.R. 1177/S. 492), a bipartisan initiative expanding tax credits for employers hiring workers facing employment barriers. This represents MAXIMUS’s clearest bipartisan advocacy effort, with senators from both parties backing legislation that could create 350,000 jobs.

However, MAXIMUS faces significant headwinds. Democratic senators recently accused the company of profiteering from Medicaid administration, while Congress intensifies oversight of programs where MAXIMUS generates core revenue.

Broader Context

MAXIMUS navigates a congressional environment marked by simultaneous opportunity and acute political risk. Congressional scrutiny is intensifying—the GAO’s 2025 High Risk List flagged improper Medicaid payments, while Senators Ron Wyden and Elizabeth Warren accused MAXIMUS of profiting from administrative complexity that removes eligible people from coverage.

Republican welfare reform proposals like the People CARE Act (H.R. 150) create opportunities through work requirements and fraud prevention services, but increase scrutiny of contractor performance.

MAXIMUS’s tax credit advocacy enjoys rare bipartisan support, backed by Senators Bill Cassidy and Maggie Hassan and Rep. Lloyd Smucker.

Between The Lines

Congress creates both opportunities and risks for MAXIMUS in 2025. Republican-controlled House hearings on eliminating welfare fraud align with MAXIMUS’s pitch, while new federal Medicaid work requirements create massive contracting opportunities by 2027.

However, this comes amid aggressive federal fraud enforcement. The DOJ and HHS relaunched their False Claims Act Working Group targeting healthcare contractors. Most damaging: Wyden and Warren’s formal letter directly accused MAXIMUS of maintaining "an abysmal track record" while positioning to profit from work requirements.

Competitive Landscape

MAXIMUS operates within a broad coalition on tax credits. The National Employment Opportunities Network spent $47,000 on H.R. 1177/S. 492, while ADP LLC spent $60,000 on related issues.

On government contracting, MAXIMUS faces competitive pressure from major Medicaid contractors including Deloitte, GDIT, Gainwell Technologies, and Conduent—all subject to similar congressional scrutiny, suggesting industry-wide rather than company-specific vulnerability.

The Bottom Line

MAXIMUS’s lobbying reflects a company pursuing opposing political trajectories. Its Work Opportunity Tax Credit advocacy enjoys genuine bipartisan support, while its core Medicaid business faces intense scrutiny from Democratic senators and aggressive federal fraud enforcement. The company’s success depends on whether it can capitalize on Republican demand for welfare reform while weathering Democratic accountability pressure—a precarious balancing act in an increasingly polarized environment.